| |
| |
|
| Insider
Information: |
Schonharting Florian |
| Relationship: |
10% Owner |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
12,488,643 |
|
|
Indirect Shares
|
21,650,325 |
|
|
| Direct
Value |
$4,526,233 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
34,138,968 |
|
|
| Total
Value |
$4,526,233 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Osteologix, Inc. |
OLGXF |
10% Owner |
2010-06-11 |
20,000 |
2010-06-11 |
21,650,325 |
Premium* |
|
|
Novelion Therapeutics Inc |
NVLN |
10% Owner |
2014-07-11 |
6,447,626 |
|
0 |
Premium* |
|
|
Astex Pharmaceuticals Inc |
ASTX |
10% Owner |
2010-04-26 |
6,021,017 |
2009-08-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVLN |
Novelion Therapeutics Inc |
10% Owner |
– – • |
2014-07-11 |
4 |
S |
$5.80 |
$5,800,000 |
D/D |
(1,000,000) |
6,447,626 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
10% Owner |
– – • |
2012-05-16 |
4 |
B |
$6.67 |
$333,340 |
D/D |
50,000 |
7,447,626 |
2.45 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
10% Owner |
– – • |
2011-08-29 |
4 |
S |
$7.08 |
$1,416,860 |
D/D |
(200,000) |
7,527,613 |
0 |
- |
|
| OLGXF |
Osteologix, Inc. |
10% Owner |
– – • |
2010-06-11 |
4 |
B |
$0.50 |
$749,956 |
I/I |
1,494,532 |
6,517,264 |
1.5 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
10% Owner |
– – • |
2010-04-26 |
4 |
S |
$3.08 |
$357,231 |
D/D |
(115,000) |
6,021,017 |
0 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
10% Owner |
– – • |
2010-04-23 |
4 |
S |
$3.06 |
$834,258 |
D/D |
(266,399) |
6,136,017 |
0 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
10% Owner |
– – • |
2010-04-22 |
4 |
S |
$3.15 |
$927,365 |
D/D |
(284,506) |
6,405,216 |
0 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
10% Owner |
– – • |
2010-04-22 |
4 |
S |
$3.38 |
$9,466 |
D/D |
(2,800) |
6,402,416 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
10% Owner |
– – • |
2010-03-16 |
4 |
B |
$4.97 |
$203,977 |
D/D |
40,896 |
7,727,613 |
2.45 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
10% Owner |
– – • |
2010-03-15 |
4 |
B |
$4.92 |
$334,008 |
D/D |
67,421 |
7,686,717 |
2.45 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
10% Owner |
– – • |
2010-03-12 |
4 |
B |
$4.86 |
$753,434 |
D/D |
152,268 |
7,619,296 |
2.45 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
10% Owner |
– – • |
2010-03-11 |
4 |
B |
$4.82 |
$633,989 |
D/D |
130,178 |
7,467,028 |
2.45 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
10% Owner |
– – • |
2010-03-10 |
4 |
B |
$4.68 |
$386,877 |
D/D |
80,286 |
7,336,850 |
2.45 |
- |
|
| OLGXF |
Osteologix, Inc. |
10% Owner |
– – • |
2010-01-07 |
4 |
B |
$0.05 |
$103,407 |
I/I |
1,992,428 |
5,022,732 |
1.5 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
10% Owner |
– – • |
2009-10-23 |
4 |
B |
$2.39 |
$119,984 |
D/D |
50,000 |
6,689,722 |
2.45 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
10% Owner |
– – • |
2009-10-21 |
4 |
S |
$3.20 |
$6,400,000 |
D/D |
(2,000,000) |
7,256,564 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
10% Owner |
– – • |
2009-10-19 |
4 |
S |
$3.90 |
$1,046,009 |
D/D |
(263,801) |
9,256,564 |
0 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
10% Owner |
– – • |
2009-09-16 |
4 |
B |
$2.92 |
$232,390 |
D/D |
78,138 |
6,639,722 |
2.45 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
10% Owner |
– – • |
2009-09-15 |
4 |
B |
$2.88 |
$105,052 |
D/D |
36,355 |
6,561,584 |
2.45 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
10% Owner |
– – • |
2009-09-14 |
4 |
B |
$2.85 |
$68,329 |
D/D |
23,700 |
6,525,229 |
2.45 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
10% Owner |
– – • |
2009-09-04 |
4 |
B |
$2.87 |
$21,308 |
D/D |
7,400 |
6,501,529 |
2.37 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
10% Owner |
– – • |
2009-08-27 |
4 |
B |
$2.81 |
$30,743 |
D/D |
10,950 |
6,235,577 |
2.37 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
10% Owner |
– – • |
2009-08-26 |
4 |
B |
$2.81 |
$11,521 |
D/D |
4,100 |
6,224,627 |
2.37 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
10% Owner |
– – • |
2009-08-25 |
4 |
B |
$2.76 |
$173,392 |
D/D |
62,242 |
6,220,527 |
2.45 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
10% Owner |
– – • |
2009-08-18 |
4 |
B |
$2.59 |
$145,798 |
D/D |
55,582 |
6,140,582 |
2.45 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
